Início › Carcinoma de Células Escamosas de Cabeça e Pescoço › Arkansas

Ensaios clínicos de Carcinoma de Células Escamosas de Cabeça e Pescoço em Arkansas

11 estudos para Carcinoma de Células Escamosas de Cabeça e Pescoço estão buscando participantes em locais em Arkansas.

Cidades em Arkansas

Texto oficial do estudo (Inglês)

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

University of Arkansas for Medical Sciences, Little Rock

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06992427

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

University of Arkansas for Medical Sciences, Little Rock

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06589804

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

University of Arkansas for Medical Sciences, Little Rock

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05136196

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

University of Arkansas for Medical Sciences, Little Rock

RecrutandoFase 2

Idades de 18 a 79 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT04671667

Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence

Highlands Oncology Group, PA, Fayetteville
University of Arkansas for Medical Sciences, Little Rock
Highlands Oncology Group, PA, Rogers
e mais 1

RecrutandoFase 2

Idades de 18 a 100 · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT05952934

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Mercy Hospital Fort Smith, Fort Smith
CARTI Cancer Center, Little Rock

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 14 de set. de 2026 · NCT02734537

ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours

Highlands Oncology Group, Rogers

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06597721

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

University of Arkansas for Medical Sciences, Little Rock

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT04333537

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT06532279

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Highlands Oncology Group, Fayetteville
Highlands Oncology Group, Rogers
Highlands Oncology Group, Springdale

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 6 de jul. de 2026 · NCT04389632

A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma

GSK Investigational Site, Jonesboro

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 26 de mai. de 2026 · NCT06256588

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.